These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

772 related items for PubMed ID: 18615849

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Apolipoprotein E epsilon4 allele and lorazepam effects on memory in high-functioning older adults.
    Pomara N, Willoughby L, Wesnes K, Greenblatt DJ, Sidtis JJ.
    Arch Gen Psychiatry; 2005 Feb; 62(2):209-16. PubMed ID: 15699298
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
    Devanand DP, Pelton GH, Zamora D, Liu X, Tabert MH, Goodkind M, Scarmeas N, Braun I, Stern Y, Mayeux R.
    Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.
    Stonnington CM, Snyder PJ, Hentz JG, Reiman EM, Caselli RJ.
    J Clin Psychiatry; 2009 Oct; 70(10):1379-84. PubMed ID: 19573495
    [Abstract] [Full Text] [Related]

  • 12. Apolipoprotein E and cognitive performance: a meta-analysis.
    Small BJ, Rosnick CB, Fratiglioni L, Bäckman L.
    Psychol Aging; 2004 Dec; 19(4):592-600. PubMed ID: 15584785
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Apolipoprotein E epsilon4 and change in cognitive functioning in community-dwelling older adults.
    Swan GE, Lessov-Schlaggar CN, Carmelli D, Schellenberg GD, La Rue A.
    J Geriatr Psychiatry Neurol; 2005 Dec; 18(4):196-201. PubMed ID: 16306239
    [Abstract] [Full Text] [Related]

  • 15. Do apolipoprotein E genotype and educational attainment predict the rate of cognitive decline in normal aging? A 12-year follow-up of the Maastricht Aging Study.
    Van Gerven PW, Van Boxtel MP, Ausems EE, Bekers O, Jolles J.
    Neuropsychology; 2012 Jul; 26(4):459-72. PubMed ID: 22642392
    [Abstract] [Full Text] [Related]

  • 16. APOE-epsilon4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis.
    Portaccio E, Goretti B, Zipoli V, Nacmias B, Stromillo ML, Bartolozzi ML, Siracusa G, Guidi L, Federico A, Sorbi S, De Stefano N, Amato MP.
    Mult Scler; 2009 Dec; 15(12):1489-94. PubMed ID: 19965518
    [Abstract] [Full Text] [Related]

  • 17. EEG functional connectivity and ApoE genotype in Alzheimer's disease and controls.
    Kramer G, van der Flier WM, de Langen C, Blankenstein MA, Scheltens P, Stam CJ.
    Clin Neurophysiol; 2008 Dec; 119(12):2727-32. PubMed ID: 18848805
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cognitive impairment in Alzheimer's disease is modified by APOE genotype.
    van der Vlies AE, Pijnenburg YA, Koene T, Klein M, Kok A, Scheltens P, van der Flier WM.
    Dement Geriatr Cogn Disord; 2007 Dec; 24(2):98-103. PubMed ID: 17596691
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.